Call alert · Horizon Europe · Cluster 1 Health
Clinical trials for advancing innovative interventions for neurodegenerative diseases
HORIZON-HLTH-2027-02-DISEASE-14-two-stage
HORIZON-HLTH-2027-02-DISEASE-14-two-stage — “Clinical trials for advancing innovative interventions for neurodegenerative diseases” — is an open Horizon Europe call. Proposals can be submitted on the EU Funding & Tenders Portal until 17 February 2027.
Key facts
- Call identifier
- HORIZON-HLTH-2027-02-DISEASE-14-two-stage
- Programme
- Horizon Europe · Cluster 1 Health
- Status
- Open
- Opens
- 29 October 2026
- Deadline
- 17 February 2027 (105 days left)
- Budget
- ≈ €10M / project
- Keywords
- Clinical research, Interventions, Neurodegeneration, Neurodegenerative diseases, Neurological
Official call page
HORIZON-HLTH-2027-02-DISEASE-14-two-stage on the EU Funding & Tenders Portal — eligibility conditions, topic description, expected outcomes and submission system.
Frequently asked questions
When is the deadline for HORIZON-HLTH-2027-02-DISEASE-14-two-stage?
The deadline is 17 February 2027. Funding & Tenders Portal deadlines usually close at 17:00 Brussels time; always confirm the exact time on the official call page.
What is the budget of HORIZON-HLTH-2027-02-DISEASE-14-two-stage?
The published budget is ≈ €10M / project.
Where do I apply for HORIZON-HLTH-2027-02-DISEASE-14-two-stage?
Proposals are submitted electronically through the EU Funding & Tenders Portal, using the link to the official call page on this page.